Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04691570
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)

Who this might be right for
Warm Autoimmune Hemolytic Anemia (wAIHA)
Annexon, Inc. 7
Early research (Phase 1)Study completedNCT00745186
What this trial is testing

Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers

Who this might be right for
Hypoglycemia
Hospira, now a wholly owned subsidiary of Pfizer 28
Early research (Phase 1)Study completedNCT05974969
What this trial is testing

Assess the PK, PD, Safety and Immunogenicity of Single IV Infusion of BCD-264 and Darzalex in Healthy Subjects

Who this might be right for
Healthy
Biocad 146
Early research (Phase 1)Study completedNCT01914796
What this trial is testing

A Phase I Trial to Investigate the Safety and Tolerability of PF-06412562

Who this might be right for
Healthy
Pfizer 39
Early research (Phase 1)Study completedNCT04555486
What this trial is testing

Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients

Who this might be right for
Primary Hyperoxaluria Type 3
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 6
Early research (Phase 1)Ended earlyNCT00927459
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Liposomal siRNA in Subjects With High Cholesterol

Who this might be right for
Hypercholesterolemia
Arbutus Biopharma Corporation 23
Early research (Phase 1)Study completedNCT01981694
What this trial is testing

A Phase I Trial to Investigate the Safety and Tolerability of PF-06649751

Who this might be right for
Healthy
Pfizer 18
Early research (Phase 1)UnknownNCT04627116
What this trial is testing

An Ascending, Multiple-Dose, Safety and Tolerability Study of Tecarfarin in Healthy Chinese Volunteers

Who this might be right for
Healthy Chinese Volunteers
Lee's Pharmaceutical Limited 40
Testing effectiveness (Phase 2)Study completedNCT02858492
What this trial is testing

Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 52
Not applicableNot Yet RecruitingNCT07593911
What this trial is testing

Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases

Who this might be right for
Systemic Lupus Erthematosus (SLE)Lupus Nephritis (LN)Multiple Sclerosis+3 more
Beijing GoBroad Hospital 75
Testing effectiveness (Phase 2)Study completedNCT06973681
What this trial is testing

BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects

Who this might be right for
Overweight or Obesity
BrightGene Bio-Medical Technology Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT03551730
What this trial is testing

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 3 of 4)

Who this might be right for
Healthy Volunteers
Portola Pharmaceuticals 27
Early research (Phase 1)Study completedNCT04778137
What this trial is testing

The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD and Safety

Who this might be right for
Asthma
Taizhou Mabtech Pharmaceutical Co.,Ltd 114
Early research (Phase 1)Study completedNCT05470829
What this trial is testing

A Multiple-dose Study in Chinese Subjects to Evaluate Safety,Tolerability,PK and PD of ZM-H1505R

Who this might be right for
Healthy VolunteersHepatitis B, Chronic
Shanghai Zhimeng Biopharma, Inc. 42
Early research (Phase 1)Looking for participantsNCT07182656
What this trial is testing

Safety, Tolerability, and PK/PD of CIGB-814 in Chinese Health Participants

Who this might be right for
Rheumatoid Arthritis (RA)
Yi Fang 70
Early research (Phase 1)Ended earlyNCT02132429
What this trial is testing

Phase I, Double-Blind,Placebo, MAD Study to Evaluate the Safety, Tolerability, PK, and PD of AMG 333 in Healthy Subjects and Migraine Subjects

Who this might be right for
Migraine
Amgen 16
Early research (Phase 1)Study completedNCT03919890
What this trial is testing

A Two-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-7684 in Healthy Adult Volunteers

Who this might be right for
Venous Thromboembolism
Ono Pharmaceutical Co., Ltd. 72
Early research (Phase 1)Study completedNCT02570074
What this trial is testing

PK/PD and Safety/Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adults

Who this might be right for
Healthy Subjects
Vance Fowler, M.D. 19
Early research (Phase 1)UnknownNCT03550508
What this trial is testing

Safety, Tolerability and PK/PD of JMT103 in Patients With Bone Metastases From Tumors

Who this might be right for
Bone Metastases
Shanghai JMT-Bio Inc. 36
Testing effectiveness (Phase 2)Study completedNCT00387751
What this trial is testing

Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage III Skin MelanomaStage IV Skin Melanoma
National Cancer Institute (NCI) 14
Next Page